Close Menu

This article has been updated from a previous version to reflect the updated name of the SARS-CoV-2 virus, which was previously named 2019-nCoV.

NEW YORK – Qiagen is developing a pair of molecular assays to detect SARS-CoV-2, the virus that causes COVID-19, from nasal swabs of symptomatic patients, a company executive said this week.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.